Shetty Sachin B, Biswas Jyotirmay, Murali Sowmiya
Vitreo-Retina & Uvea Services, Sadguru Netra Chikitsalaya, Jankikund Post, Chitrakoot, U.P., 210204, India.
Uveitis & Ocular Pathology Department, Vision Research Foundation, 18, College Road, Nungambakkam, Chennai, 600006, Tamil Nadu, India.
J Ophthalmic Inflamm Infect. 2014 Dec;4(1):29. doi: 10.1186/s12348-014-0029-5. Epub 2014 Nov 18.
The term multifocal serpiginoid choroiditis (MSC) has been proposed for the infective variant of serpiginous choroiditis (SC) to distinguish it from typical SC believed to be autoimmune related. The role of Mycobacterium tuberculosis (MTb) in MSC has been studied by conventional polymerase chain reaction (PCR). However, the use of real-time PCR (RT-PCR) and nested PCR (N-PCR) in MSC has not been reported. This paper aims to highlight the usefulness of PCR in identifying MTb as a causative agent for MSC leading to its correct treatment with anti-tubercular therapy (ATT).
A young male with a family history of tuberculosis (TB) presented with a history of diminution of vision (DOV) since 3 months in his right eye (RE). He gave similar history in his left eye (LE) since 3 years. His fundus findings were suggestive of MSC. His high-resolution computed tomography (HRCT) chest and Quanti-FERON TB gold results were positive for MTb. These suggested TB to be the likely cause for MSC. This was confirmed by a positive N-PCR report of his aqueous specimen. Further RT-PCR was done to quantify the bacillary load before starting therapy. He was advised 9 months of ATT with 6 weeks of oral steroids. At last follow-up, the RE showed better healing than the LE with fewer chorioretinal scars and a better visual acuity.
RT and N-PCR for MTb are useful in establishing a tuberculous etiology in MSC. Coupled with a good response to ATT, these tests justify the use of ATT in MSC with a PCR-confirmed MTb report.
多灶性匐行性脉络膜炎(MSC)这一术语已被用于匐行性脉络膜炎(SC)的感染性变体,以将其与被认为与自身免疫相关的典型SC区分开来。传统聚合酶链反应(PCR)已对结核分枝杆菌(MTb)在MSC中的作用进行了研究。然而,实时PCR(RT-PCR)和巢式PCR(N-PCR)在MSC中的应用尚未见报道。本文旨在强调PCR在鉴定MTb作为MSC病原体方面的作用,从而通过抗结核治疗(ATT)实现对其的正确治疗。
一名有结核病(TB)家族史的年轻男性,右眼(RE)自3个月前出现视力下降(DOV)病史。左眼(LE)自3年前起有类似病史。其眼底检查结果提示为MSC。他的胸部高分辨率计算机断层扫描(HRCT)和结核感染T细胞检测(Quanti-FERON TB gold)结果显示MTb呈阳性。这些提示TB可能是MSC的病因。其房水标本的N-PCR报告呈阳性,证实了这一点。在开始治疗前进一步进行RT-PCR以量化细菌载量。建议他接受9个月的ATT治疗,并联合6周的口服类固醇治疗。在最后一次随访时,右眼的愈合情况优于左眼,脉络膜视网膜瘢痕较少,视力更好。
针对MTb的RT-PCR和N-PCR有助于确立MSC的结核病因。结合对ATT的良好反应,这些检测证明在有PCR确诊MTb报告的MSC中使用ATT是合理的。